Handelsbanken Fonder’s Supernus Pharmaceuticals SUPN Stock Holding History

Handelsbanken Fonder’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$964K	Buy	20,716 +1,700	+9%	+$81.6K	﹤0.01%	1157
2026 Q1	$983K	Hold	19,016	–	–	﹤0.01%	1049
2025 Q4	$945K	Hold	19,016	–	–	﹤0.01%	1054
2025 Q3	$909K	Buy	19,016 +700	+4%	+$28.2K	﹤0.01%	1044
2025 Q2	$577K	Sell	18,316 -800	-4%	-$25.6K	﹤0.01%	1189
2025 Q1	$626K	Hold	19,116	–	–	﹤0.01%	1153
2024 Q4	$691K	Buy	19,116 +1,900	+11%	+$66.9K	﹤0.01%	1158
2024 Q3	$537K	Hold	17,216	–	–	﹤0.01%	1210
2024 Q2	$461K	Buy	17,216 +4,800	+39%	+$139K	﹤0.01%	1193
2024 Q1	$424K	Hold	12,416	–	–	﹤0.01%	1236
2023 Q4	$359K	Hold	12,416	–	–	﹤0.01%	1311
2023 Q3	$342K	Hold	12,416	–	–	﹤0.01%	1254
2023 Q2	$373K	Hold	12,416	–	–	﹤0.01%	1231
2023 Q1	$450K	Hold	12,416	–	–	﹤0.01%	1046
2022 Q4	$443K	Hold	12,416	–	–	﹤0.01%	1026
2022 Q3	$420K	Hold	12,416	–	–	﹤0.01%	1065
2022 Q2	$359K	Hold	12,416	–	–	﹤0.01%	1222
2022 Q1	$401K	Sell	12,416 -4,200	-25%	-$129K	﹤0.01%	1356
2021 Q4	$485K	Hold	16,616	–	–	﹤0.01%	1373
2021 Q3	$443K	Hold	16,616	–	–	﹤0.01%	1428
2021 Q2	$512K	Buy	16,616 +6,600	+66%	+$202K	﹤0.01%	1363
2021 Q1	$262K	Hold	10,016	–	–	﹤0.01%	1485
2020 Q4	$252K	Hold	10,016	–	–	﹤0.01%	1465
2020 Q3	$209K	Hold	10,016	–	–	﹤0.01%	1379
2020 Q2	$238K	Buy	+10,016	New	+$221K	﹤0.01%	1318

Other funds holding SUPN

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Handelsbanken Fonder's SUPN Position: Q2 2026 in Review

Handelsbanken Fonder increased its Supernus Pharmaceuticals (SUPN) stake by 8.9% in Q2 2026, buying an estimated $81.6K and bringing the position to 20,716 shares worth $964K. The position accounts for ﹤0.01% of the portfolio, ranked #1157.

Handelsbanken Fonder first reported a position in SUPN in Q2 2020 and has held it in 25 quarters since. The position peaked at $983K in Q1 2026. 84 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Handelsbanken Fonder held 20,716 shares of Supernus Pharmaceuticals worth $964K as of Q2 2026.
Handelsbanken Fonder bought 1,700 Supernus Pharmaceuticals shares in Q2 2026, an estimated $81.6K.
Supernus Pharmaceuticals made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1157 holding.
Handelsbanken Fonder first reported a position in Supernus Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
Handelsbanken Fonder's Supernus Pharmaceuticals position peaked at $983K in Q1 2026.
84 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.